FDA Inspection 1305800 — Leo Pharma A/S
The FDA completed an inspection of Leo Pharma A/S on Sep 26, 2024 in Ballerup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ballerup (Denmark)
Additional details
Mutual Recognition Agreement (MRA)